< Back to latest news & events

Event

WIPR Patents Live webinar: Protecting medical devices in Europe—avoiding common pitfalls

July 2021

Event date: 20th July 2021

WIPR Patents Live is holding a complimentary session on July 20, at 5pm BST/12pm ET, where HGF Partner & Patent Attorney Kieran Killough will present on ‘Protecting medical devices in Europe—avoiding common pitfalls’.

Throughout the last decade, medical devices have been the subject of the most patent applications filed at the European Patent Office every year—for all but one year. This dominance reflects the year-on-year increase in investment poured into the medical device sector and, with the world currently focused on healthcare more than ever, this trend looks set to continue.

However, with approximately two-thirds of European medical device patent applications originating from outside Europe, most have not been drafted with the challenges of the European patent system and market in mind.

Together with a changing regulatory backdrop, medical device IP owners often find themselves falling foul of Europe-specific issues that may limit the scope of protection that may be achieved or, at the very least, increase costs and add delay.

In this session we will:

  • Review Europe-specific issues that regularly cause trouble for medical device patent applicants in Europe
  • Explore options for building resilience into patent applications that are destined for Europe, and will consider how to navigate objections when they arise
  • Provide insight into potential IP issues that may arise from the new EU medical device regulations, and what steps can be taken to reduce the risks posed.

Latest updates

The concept of ‘overall impression’ in UK and EU Registered Design Law

 

Read article

The Antibody Series #2 | Definition via binding strength in antibody claims: when “binds strongly... but only minimally...” becomes a trap of lack of clarity

Introduction Defining an antibody by its binding strength is common practice in patent claims, but it can quickly become a pitfall under Article 84 EPC on clarity. In this second …

Read article

The Antibody Series #1 | Quality Characteristics (CQAs) in Antibody Claims: When the Test Method Can Remain Outside the Claim

Introduction Therapeutic antibodies are at the heart of innovations in biotechnology and healthcare. With increasing regulatory requirements and quality expectations, critical quality attributes (CQAs) are becoming essential in the drafting …

Read article
Event - 7th January 2026

HGF Brand & Design Conference 2026

Join us on 3rd February 2026 for HGF’s Brand & Design Conference, the must attend event for in-house legal teams, brand leaders, creatives, and innovators shaping the future of IP. …

Event details

Empowered, Not Replaced: The Risks and Rewards of Using AI Tools in Patent Prosecution

With the rapid rise of AI and extreme hype around generative AI tools in the workplace, patent firms around the world have had to seriously consider to what extent they …

Read article

EU Agrees on NGT Plant Regulation: What It Means for Patents and Licensing

The European Parliament and Council have reached a provisional agreement for plants developed using New Genomic Techniques (NGTs) – below we summarise the main points and set out the requirements …

Read article

When Retail Branding Meets Politics

(Inter IKEA Systems v Algemeen Vlaams Belang (Case C‑298/23) In November 2022, the Flemish political party Vlaams Belang presented its “IKEA-PLAN – Immigratie Kan Echt Anders” (“Immigration Really Can Be Different”). …

Read article

Office Closed Dates December 2025 / January 2026

HGF Office Closed Dates December 2025 / January 2026   UK Thursday 25 and Friday 26 December 2025 CLOSED Thursday 1 January 2026* CLOSED * Friday 2 January 2026 – …

Read article